GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
What is the latest Consolidated Net Profit of GLAND PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹772 Cr |
| Mar2024 | ₹781 Cr |
| Mar2023 | ₹1,212 Cr |
| Mar2022 | ₹997 Cr |
| Mar2021 | ₹773 Cr |
How is Consolidated Net Profit of GLAND PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹772 Cr | -1.10 | |
| Mar2024 | ₹781 Cr | -35.54 | |
| Mar2023 | ₹1,212 Cr | 21.54 | |
| Mar2022 | ₹997 Cr | 29.00 | |
| Mar2021 | ₹773 Cr | - | |
Compare Consolidated Net Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹31,269.2 Cr | 9.7% | 6.7% | 28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 9.7% |
6.7% |
28.1% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses